Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New monoamine reuptake inhibitors developed at NeuroSearch

Oct. 13, 2004

Takeda presents metastin derivatives for cancer therapy and other uses

Oct. 13, 2004

New inhibitors of ERK2, GSK-3, PKA and CDK2 presented by Vertex

Oct. 11, 2004

New CDK inhibitors in early development at Pfizer

Oct. 11, 2004

New 5-HT1A ligands/5-HT reuptake inhibitors covered by Merck KGaA patent

Oct. 11, 2004

Novartis scientists prepare and test new protein kinase C inhibitors

Oct. 11, 2004

Novel tachykinin NK2/NK3 ligands discovered at Merck

Oct. 11, 2004

Bayer claims new proteasome inhibitors for asthma and cancer

Oct. 11, 2004

Novel NMDA GlyB-site antagonists discovered at Gruenenthal

Oct. 11, 2004

New Hsp90 inhibitors and their use in cancer and other disorders

Oct. 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...